Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis

NCT03157284 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2019-12-18

No results posted yet for this study

Summary

This Study Evaluate the efficacy of the subministration of fermented rice flour (7 g/day) on the clinical course of patients with moderate or severe Atopic Dermatitis, in terms of a reduction in the SCORAD score, during the study period and four weeks after the suspension of the treatment.

Conditions

Interventions

DIETARY_SUPPLEMENT

Rice Flour

For 12 weeks, a group of children will receive 7gr fermented rice flour according to a randomised, double-blind design.

DIETARY_SUPPLEMENT

Placebo

For 12 weeks a group of children will receive a 7gr of a placebo (maltodextrin), according to a randomised, double-blind design.

Sponsors & Collaborators

  • Heinz Italia SpA

    lead INDUSTRY

Principal Investigators

  • EnzaCarmina D'Auria, Dott · Clinica Pediatrica Ospedale dei Bambini Vittore Buzzi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
6 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-23
Primary Completion
2019-05-24
Completion
2019-05-29

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03157284 on ClinicalTrials.gov